Stock Compensation

6 Months Ended

Jun. 30, 2020

Share-based Payment Arrangement [Abstract]

STOCK COMPENSATIONThe Corporation has a stock incentive plan, which is administered by a committee of the Board of Directors and which permits the Corporation to provide various types of stock-based compensation to its key employees, directors, and/or consultants, including time-based and performance-based shares of restricted stock. The Corporation previously maintained the CNB Financial Corporation 2009 Stock Incentive Plan, which terminated in accordance with its terms on February 10, 2019, and currently maintains the CNB Financial Corporation 2019 Omnibus Incentive Plan (the "2019 Stock Incentive Plan"), which was approved by the Corporation’s shareholders and became effective on April 16, 2019.

For key employees, the vesting of time-based restricted stock is one-third, one-fourth, or one-fifth of the granted restricted shares per year, beginning one year after the grant date, with 100% vesting on the third, fourth or fifth anniversary of the grant date, respectively. Prior to 2018, for non-employee directors, the vesting schedule was one-third of the granted restricted shares per year, beginning one year after the grant date, with 100% vested on the third anniversary of the grant date. Beginning in 2018, stock compensation received by non-employee directors vests immediately. At June 30, 2020, there was no unrecognized compensation cost related to stock-based compensation awarded under this plan and, except for the time-based and performance-based restricted stock awards disclosed below and in previous filings, no other stock-based compensation was granted during the three or six month periods ended June 30, 2020 and 2019.

In addition to the time-based restricted stock disclosed above, the Corporation’s Board of Directors grants performance-based restricted stock awards (“PBRSAs”) to key employees. The number of PBRSAs will depend on certain performance conditions earned over a three year period and are also subject to service-based vesting. In 2020, awards with a maximum of 18,100 shares in aggregate were granted to key employees. In 2019, awards with a maximum of 16,681 shares in aggregate were granted to key employees. In 2018, awards with a maximum of 15,657 shares in aggregate were granted to key employees.

Compensation expense for the restricted stock awards is recognized over the requisite service period noted above based on the fair value of the shares at the date of grant. Nonvested restricted stock awards are recorded as a reduction of additional paid-in-capital in shareholders’ equity until earned. Compensation expense resulting from time-based, performance-based and director restricted stock awards was $286 and $835 for the three and six months ended June 30, 2020, respectively, and $275 and $867 for the three and six months ended June 30, 2019, respectively. There was $1,384 and $1,026 of total unrecognized compensation cost related to unvested restricted stock awards, as of June 30, 2020 and December 31, 2019, respectively. The total income tax benefit related to the recognized compensation cost of vested restricted stock awards was $60 and $175 for the three and six months ended June 30, 2020, respectively, and $58 and $182 for the three and six months ended June 30, 2019, respectively.

A summary of changes in time-based nonvested restricted stock awards for the three months ended June 30, 2020 follows:


	Shares	Per Share Weighted Average Grant Date Fair Value
Nonvested at beginning of period	55,766	$	27.42
Granted	0	0.00

Vested	(300)	17.83
Nonvested at end of period	55,466	$	27.47

A summary of changes in time-based nonvested restricted stock awards for the six months ended June 30, 2020 follows:


	Shares	Per Share Weighted Average Grant Date Fair Value
Nonvested at beginning of period	58,370	$	24.96
Granted	23,658	29.56

Vested	(26,562)	24.01
Nonvested at end of period	55,466	$	27.47

The above table excludes 11,502 shares in restricted stock awards that were granted at a weighted average fair value of $29.56 and immediately vested. Compensation expense resulting from the immediately vested shares was $0 and $340 for the three and six months ended June 30, 2020, respectively, and is included in the amounts discussed above.

The fair value of shares vested was $5 and $1,106 during the three and six months ended June 30, 2020, respectively, and $101 and $1,328 for the three and six months ended June 30, 2019, respectively.